TY - JOUR
T1 - EML4/ALK and Ras Inhibitors
AU - Edelman, Martin J.
PY - 2010/12
Y1 - 2010/12
KW - Anaplastic Lymphoma Kinase
KW - Antineoplastic Agents/therapeutic use
KW - Carcinoma, Non-Small-Cell Lung/drug therapy
KW - Cell Cycle Proteins/antagonists & inhibitors
KW - Clinical Trials as Topic
KW - Humans
KW - Lung Neoplasms/drug therapy
KW - Microtubule-Associated Proteins/antagonists & inhibitors
KW - Protein-Tyrosine Kinases/antagonists & inhibitors
KW - Receptor Protein-Tyrosine Kinases
KW - Serine Endopeptidases
KW - ras Proteins/antagonists & inhibitors
UR - http://www.scopus.com/inward/record.url?scp=79952458263&partnerID=8YFLogxK
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:000284994000021&DestLinkType=FullRecord&DestApp=WOS
U2 - 10.1097/01.JTO.0000391381.40050.5c
DO - 10.1097/01.JTO.0000391381.40050.5c
M3 - Article
C2 - 21102254
SN - 1556-0864
VL - 5
SP - S495-S496
JO - Journal of Thoracic Oncology
JF - Journal of Thoracic Oncology
IS - 12 Suppl 6
ER -